Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112125970A reveals a novel solid-phase synthesis for Semaglutide using specialized Asp protection and fragment condensation to enhance yield and purity for reliable API manufacturing.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Patent CN102875665A reveals a high-yield fragment condensation method for Liraglutide, offering superior purity and cost-effective manufacturing alternatives to recombinant technologies.
Patent CN103864918A reveals efficient fragment condensation for liraglutide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Novel Fmoc solid-phase route for Telaprevir reduces cost and complexity. High purity API intermediate manufacturing solution for global supply chains.
Novel solid-phase synthesis of Goserelin avoids palladium reduction. Enhances purity and supply chain reliability for pharmaceutical manufacturing partners globally.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Novel segment condensation method enhances thymalfasin purity and reduces impurities for scalable pharmaceutical intermediates manufacturing and supply chain stability.
Patent CN115991738A details a novel solid-phase synthesis for Plecanatide using orthogonal S-Tmp and Acm protection, ensuring high purity and commercial scalability for pharmaceutical manufacturers.
Patent CN106854235B reveals a novel solid-phase fragment method for Carbetocin, offering high purity and reduced solvent waste for pharmaceutical manufacturing.
Patent CN113801199B details novel Mitsunobu cyclization for carbetocin. Enhances purity and yield while reducing manufacturing costs for reliable supply chains.
Patent CN106892968B reveals a novel selective oxidation strategy for Linaclotide. Achieve high purity and yield with our scalable peptide manufacturing solutions.
Patent CN110642936A details a high-yield fragment condensation method for teriparatide, offering superior purity and cost-effective manufacturing for global supply chains.
Advanced solid-phase synthesis of Somaglutide via CN108359006B ensures high purity and yield. Discover cost-effective scalable manufacturing for global supply chains.
Patent CN104311639B details advanced solid-phase synthesis for somatostatin. Achieve higher purity and yield with optimized temperature control and resin selection.
Novel solid-phase synthesis avoids HF and TFA. Reduces waste and cost for scalable octreotide acetate manufacturing.
Patent CN108676086A reveals novel Depsipeptide strategy for Liraglutide. Enhances purity, yield, and supply chain reliability for global pharmaceutical procurement.
Novel solid-liquid synthesis method for Liraglutide improves purity and yield. Reduces impurities and simplifies purification for reliable supply chain partners.
Patent CN113412272A details a novel 5+11 fragment condensation strategy for Plecanatide, offering enhanced purity and scalable manufacturing for pharmaceutical intermediates.